Jag Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-29,203
| Closed | -$1.98M | – | 140 |
|
|
2023
Q3 | $1.98M | Sell |
29,203
-101
| -0.3% | -$6.84K | 0.24% | 72 |
|
|
2023
Q2 | $2.1M | Buy |
29,304
+1,325
| +5% | +$94.8K | 0.24% | 70 |
|
|
2023
Q1 | $1.94M | Buy |
27,979
+13,995
| +100% | +$971K | 0.25% | 75 |
|
|
2022
Q4 | $948K | Buy |
13,984
+7,825
| +127% | +$531K | 0.14% | 97 |
|
|
2022
Q3 | $338K | Sell |
6,159
-362
| -6% | -$19.9K | 0.05% | 146 |
|
|
2022
Q2 | $431K | Sell |
6,521
-393
| -6% | -$26K | 0.05% | 137 |
|
|
2022
Q1 | $344K | Buy |
6,914
+658
| +11% | +$32.7K | 0.03% | 168 |
|
|
2021
Q4 | $364K | Sell |
6,256
-20
| -0.3% | -$1.16K | 0.03% | 168 |
|
|
2021
Q3 | $377K | Sell |
6,276
-664
| -10% | -$39.9K | 0.03% | 176 |
|
|
2021
Q2 | $416K | Buy |
6,940
+26
| +0.4% | +$1.56K | 0.03% | 176 |
|
|
2021
Q1 | $344K | Buy |
6,914
+6
| +0.1% | +$299 | 0.03% | 185 |
|
|
2020
Q4 | $345K | Buy |
6,908
+456
| +7% | +$22.8K | 0.03% | 164 |
|
|
2020
Q3 | $354K | Buy |
6,452
+3
| +0% | +$165 | 0.04% | 143 |
|
|
2020
Q2 | $341K | Sell |
6,449
-59
| -0.9% | -$3.12K | 0.04% | 136 |
|
|
2020
Q1 | $291K | Sell |
6,508
-1,590
| -20% | -$71.1K | 0.04% | 142 |
|
|
2019
Q4 | $404K | Buy |
8,098
+472
| +6% | +$23.5K | 0.05% | 159 |
|
|
2019
Q3 | $340K | Sell |
7,626
-41
| -0.5% | -$1.83K | 0.04% | 166 |
|
|
2019
Q2 | $317K | Buy |
+7,667
| New | +$317K | 0.04% | 174 |
|